Cognitive Effectiveness of Somatotherapy and Occupational Therapy in Post-Stroke Patients. (CESTO)
The Cognitive Effectiveness of Somatotherapy & Occupational Therapy in Post-Stroke Patients
調査の概要
詳細な説明
Stroke is a leading cause of death and long-term disability worldwide. Cognitive impairment is a common and disabling consequence of stroke that significantly affects patients' functional independence and quality of life.
Somatotherapy (targeted physical and sensorimotor therapy) and occupational therapy (focused on activities of daily living) are frequently used rehabilitation approaches, but their combined effect on cognitive recovery in post-stroke patients requires further evaluation.
This was a single-center, retrospective observational study conducted at the department of physical therapy, King Hospital, Swat, Pakistan. Medical records of 50 post-stroke patients (30 males, 20 females; age range 30-60 years) who received inpatient rehabilitation between 2018 and 2019 were analyzed.
Participants
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Khyber Pakhtunkhwa
-
Swat、Khyber Pakhtunkhwa、パキスタン、26000
- Swat Medical Complex
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
50 post-stroke patients (30 males and 20 females) who were referred to the Department of Physical Therapy at King Hospital, Swat, Pakistan between 2018 and 2019 for cognitive rehabilitation.
Participants were adult stroke patients (approximate mean age around 60 years) with either ischemic or hemorrhagic stroke who received 4 weeks of inpatient combined somatotherapy and occupational therapy.
説明
Inclusion Criteria
- Adults aged 30 years and above
- Diagnosed with ischemic or hemorrhagic stroke (first-ever or recurrent)
- Referred to physical therapy department for cognitive rehabilitation
- Received somatotherapy and occupational therapy during hospitalization
- Able to undergo MoCA (Montreal Cognitive Assessment) testing
Exclusion Criteria:
- Severe speech impairment (aphasia) that prevents reliable cognitive testing
- Significant visual impairment that interferes with MoCA testing
- Significant hearing impairment that interferes with MoCA testing
- Inability to participate in therapy sessions.
研究計画
研究はどのように設計されていますか？
デザインの詳細
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Montreal Cognitive Assessment
時間枠：4 weeks
|
To detect mild cognitive impairment and assess for early stages of dementia.
This scale utilizes a minimum value of 0 and a maximum value of 30, where higher scores mean a better outcome (a score of 26 or above is considered normal, while a score of 22 suggests mild cognitive impairment.
|
4 weeks
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- IQRA-00023
- Iqra-023 (レジストリ識別子：Clinical Trial)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
ndividual participant data will not be shared publicly. The study is a small retrospective analysis based on hospital medical records. Sharing IPD is not planned due to:
Ethical and privacy concerns (patient confidentiality and data protection regulations).
The retrospective nature of the study with no prior consent obtained from participants for data sharing.
Local institutional policies at King Hospital regarding data sharing.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Somatotherapy and Occupational Therapyの臨床試験
-
Training and Implementation Associates募集従来の対面トレーニング | 家族療法のトレーニングと実装プラットフォーム (FTTIP)アメリカ